Our numerous international contacts have enabled
us, since the beginning of the health crisis, to
provide regions and distributors with the personal
protection and antigen tests that are essential in the
fight against Covid-19.
With more than 10 years of experience of its
team and partners, BIO AMOVIR focuses its
research on a new concept of treatment of
diseases caused by enveloped viruses such as
AIDS, influenza, herpes, Covid-19
Created in 2015, BIO AMOVIR is an
R&D, Marketing , distribution and
creative company specialised in the
field of Virology.
BIO AMOVIR health products have
a quality level that ensures the
safety of patients and the
BIO AMOVIR is owned by the
SAMFI-INVEST SAS Group, Alain
Samson's family holding company,
based in Caen, Normandy.
Based on the first research results, an
innovative technology has been developed.
AMOVIR® Technology, through its barrier
action and the stimulation of the immune
system, prevents herpes from the very first
Herpes & Cold sores
BIO AMOVIR SAS
179 rue du Poirier 14650 CARPIQUET FRANCE
Capital Social : 2 000 000 € - Siret: 812 245 728 00017
©2020 par BIO AMOVIR SAS. contact: email@example.com